Captrust Financial Advisors Accolade, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$10.45 - $15.02 $31 - $45	-3 Reduced 0.02%	16,000 $169,000
Q2 2023 Aug 14, 2023	BUY	$10.52 - $16.06 $168,351 - $257,008	16,003 New	16,003 $215,000
Q2 2022 Aug 16, 2022	BUY	$5.28 - $18.9 $3,896 - $13,948	738 Added 199.46%	1,108 $8,000
Q1 2022 May 16, 2022	SELL	$12.92 - $27.18 $10,710 - $22,532	-829 Reduced 69.14%	370 $6,000
Q4 2021 Feb 14, 2022	SELL	$21.96 - $42.69 $21,323 - $41,451	-971 Reduced 44.75%	1,199 $32,000
Q2 2021 Aug 16, 2021	BUY	$38.61 - $55.0 $81,158 - $115,610	2,102 Added 3091.18%	2,170 $118,000
Q1 2021 May 17, 2021	SELL	$38.1 - $59.09 $3,505 - $5,436	-92 Reduced 57.5%	68 $3,000
Q4 2020 Feb 16, 2021	BUY	$33.26 - $59.72 $5,321 - $9,555	160 New	160 $7,000

173

68.2M

181K

1.66M

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $496M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.